Nipro Recalls Balloon Catheters In Japan
This article was originally published in PharmAsia News
Japanese major medical device maker, Osaka-based Nipro, announced a recall of two kinds of balloon catheters (totaling 5,680 devices). The reason for the recall is insufficient strength and the concern that air might get into the blood vessels. Last November, a case in which air got into a patient's blood vessels was reported in Japan. The patient later recovered through medical treatment. A loose connection between the air ball and catheter was highly suspected as a cause in that case. The two types of catheter under recall are the Sidekick and Gimlet , made between November 2006 and August 2007. A total of 247 medical facilities in Japan will be impacted by the recall. (Click here for more-Japanese language
You may also be interested in...
COVID-19 has pushed the entire health care system to adopt new technologies and new solutions for conducting clinical research and delivering care to patients. An expert panel hosted by the Galien Foundation provided a meditation on what the biopharma industry has learned so far, and how to use the urgency created by COVID-19 to lock-in technological acceleration while maintaining what FDA’s Amy Abernethy called “responsible progress.”
Zydus Cadila has clocked up two tentative and four final abbreviated new drug application approvals in a short amount of time, including for Boehringer Ingelheim’s Jentadueto and the discontinued verapamil hydrochloride for injection.
Pierre Bourdage, global head of biopharmaceuticals at Sandoz, has hit back at false statements and misleading claims around biosimilars that persist despite mounting evidence to the contrary.